Bradykinin receptor antagonists – a review of the patent literature 2005 – 2008

Author： Fincham Christopher I Bressan Alessandro Paris Marielle Rossi Cristina Fattori Daniela

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.19, Iss.7, 2009-07, pp. : 919-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen receptor antagonists: a patent review (2008 – 2011)

By Mohler Michael L Coss Christopher C Duke Charles B Patil Shivaputra A Miller Duane D Dalton James T

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 541-565

Informa Healthcare

Access to resources Recommend Favorite

Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 –– 2010)

By Malherbe Pari Ballard Theresa M Ratni Hassen

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 637-655

Informa Healthcare

Access to resources Recommend Favorite

Bradykinin B1 receptor antagonists: a patent update 2009 – 2012

By Bozó Éva Éles János Keserű György M

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1443-1452

Informa Healthcare

Access to resources Recommend Favorite

AT1 antagonists: a patent review (2008 – 2012)

By Mavromoustakos Thomas Agelis George Durdagi Serdar

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1483-1494

Informa Healthcare

Access to resources Recommend Favorite

Bradykinin B1 receptor antagonists

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1479-1482

Informa Healthcare

Access to resources Recommend Favorite